Effects of betaine on lipopolysaccharide-induced memory impairment in mice and the involvement of GABA transporter 2

Journal of Neuroinflammation

Volumn 8, Issue , 2011, Pages

  Miwa, Masaya ^a   Tsuboi, Mizuki ^a   Noguchi, Yumiko ^a   Enokishima, Aoi ^a   Nabeshima, Toshitaka ^a   Hiramatsu, Masayuki ^a  

^a MEIJO UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

4 AMINOBUTYRIC ACID CARRIER; 4 AMINOBUTYRIC ACID CARRIER 2; BETAINE; CD11B ANTIGEN; CD45 ANTIGEN; CYCLOOXYGENASE 2; GLIAL FIBRILLARY ACIDIC PROTEIN; HEME OXYGENASE 1; INDUCIBLE NITRIC OXIDE SYNTHASE; INTERLEUKIN 1BETA; LIPOPOLYSACCHARIDE; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; CYTOKINE; LIPOTROPIC AGENT; MESSENGER RNA; SLC6A12 PROTEIN, MOUSE;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CELL ACTIVATION; CONTROLLED STUDY; DOSE RESPONSE; GLIA CELL; HIPPOCAMPUS; INFLAMMATION; MALE; MAZE TEST; MEMORY; MEMORY DISORDER; MOLECULAR RECOGNITION; MOUSE; NONHUMAN; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; TASK PERFORMANCE; WORKING MEMORY; ANIMAL; BIOSYNTHESIS; CHEMICALLY INDUCED DISORDER; DRUG EFFECT; METABOLISM; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

ANIMALS; BETAINE; CYTOKINES; GABA PLASMA MEMBRANE TRANSPORT PROTEINS; INFLAMMATION; LIPOPOLYSACCHARIDES; LIPOTROPIC AGENTS; MALE; MAZE LEARNING; MEMORY DISORDERS; MICE; REAL-TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER;

EID: 80355125163     PISSN: None     EISSN: 17422094     Source Type: Journal    
DOI: 10.1186/1742-2094-8-153     Document Type: Article

References (35)

1. Craig SA. Betaine in human nutrition. Am J Clin Nutr 2004, 80:539-549.
2. Zeisel SH, Mar MH, Howe JC, Holden JM. Concentrations of choline-containing compounds and betaine in common foods. J Nutr 2003, 133:1302-1307.
3. Chen TH, Murata N. Glycinebetaine: an effective protectant against abiotic stress in plants. Trends Plant Sci 2008, 13:499-505. 10.1016/j.tplants.2008.06.007, 18703379.
4. Zeisel SH, Blusztajn JK. Choline and human nutrition. Annu Rev Nutr 1994, 14:269-296. 10.1146/annurev.nu.14.070194.001413, 7946521.
5. Kempson SA, Montrose MH. Osmotic regulation of renal betaine transport: transcription and beyond. Pflugers Arch 2004, 449:227-234.
6. Go EK, Jung KJ, Kim JM, Lim H, Lim HK, Yu BP, Chung HY. Betaine modulates age-related NF-κB by thiol-enhancing action. Biol Pharm Bull 2007, 30:2244-2249. 10.1248/bpb.30.2244, 18057706.
7. Go EK, Jung KJ, Kim JY, Yu BP, Chung HY. Betaine suppresses proinflammatory signaling during aging: the involvement of nuclear factor-κB via nuclear factor-inducing kinase/IκB kinase and mitogen-activated protein kinases. J Gerontol A Biol Sci Med Sci 2005, 60:1252-1264. 10.1093/gerona/60.10.1252, 16282556.
8. Borden LA, Smith KE, Gustafson EL, Branchek TA, Weinshank RL. Cloning and expression of a betaine/GABA transporter from human brain. J Neurochem 1995, 64:977-984.
9. Yamauchi A, Uchida S, Kwon HM, Preston AS, Robey RB, Garcia-Perez A, Burg MB, Handler JS. Cloning of a Na+- and Cl--dependent betaine transporter that is regulated by hypertonicity. J Biol Chem 1992, 267:649-652.
10. Olsen M, Sarup A, Larsson OM, Schousboe A. Effect of hyperosmotic conditions on the expression of the betaine-GABA-transporter (BGT-1) in cultured mouse astrocytes. Neurochem Res 2005, 30:855-865. 10.1007/s11064-005-6879-3, 16187220.
11. Zhu XM, Ong WY. Changes in GABA transporters in the rat hippocampus after kainate-induced neuronal injury: decrease in GAT-1 and GAT-3 but upregulation of betaine/GABA transporter BGT-1. J Neurosci Res 2004, 77:402-409. 10.1002/jnr.20171, 15248296.
12. Takanaga H, Ohtsuki S, Hosoya K, Terasaki T. GAT2/BGT-1 as a system responsible for the transport of γ-aminobutyric acid at the mouse blood-brain barrier. J Cereb Blood Flow Metab 2001, 21:1232-1239.
13. Iwai T, Iinuma Y, Kodani R, Oka J. Neuromedin U inhibits inflammation-mediated memory impairment and neuronal cell-death in rodents. Neurosci Res 2008, 61:113-119. 10.1016/j.neures.2008.01.018, 18336945.
14. Tanaka S, Ide M, Shibutani T, Ohtaki H, Numazawa S, Shioda S, Yoshida T. Lipopolysaccharide-induced microglial activation induces learning and memory deficits without neuronal cell death in rats. J Neurosci Res 2006, 83:557-566. 10.1002/jnr.20752, 16429444.
15. Yamada K, Komori Y, Tanaka T, Senzaki K, Nikai T, Sugihara H, Kameyama T, Nabeshima T. Brain dysfunction associated with an induction of nitric oxide synthase following an intracerebral injection of lipopolysaccharide in rats. Neuroscience 1999, 88:281-294. 10.1016/S0306-4522(98)00237-1, 10051207.
16. Block ML, Hong JS. Microglia and inflammation-mediated neurodegeneration: multiple triggers with a common mechanism. Prog Neurobiol 2005, 76:77-98. 10.1016/j.pneurobio.2005.06.004, 16081203.
17. Eikelenboom P, Veerhuis R, Scheper W, Rozemuller AJ, van Gool WA, Hoozemans JJ. The significance of neuroinflammation in understanding Alzheimer's disease. J Neural Transm 2006, 113:1685-1695. 10.1007/s00702-006-0575-6, 17036175.
18. Minghetti L. Role of inflammation in neurodegenerative diseases. Curr Opin Neurol 2005, 18:315-321. 10.1097/01.wco.0000169752.54191.97, 15891419.
19. Haley TJ, McCormick WG. Pharmacological effects produced by intracerebral injection of drugs in the conscious mouse. Br J Pharmacol Chemother 1957, 12:12-15. 1509635, 13413144.
20. Hiramatsu M, Sasaki M, Nabeshima T, Kameyama T. Effects of dynorphin A (1-13) on carbon monoxide-induced delayed amnesia in mice. Pharmacol Biochem Behav 1997, 56:73-79. 10.1016/S0091-3057(96)00159-1, 8981612.
21. Sarter M, Bodewitz G, Stephens DN. Attenuation of scopolamine-induced impairment of spontaneous alteration behaviour by antagonist but not inverse agonist and agonist β-carbolines. Psychopharmacology (Berl) 1988, 94:491-495.
22. Nagai T, Takuma K, Kamei H, Ito Y, Nakamichi N, Ibi D, Nakanishi Y, Murai M, Mizoguchi H, Nabeshima T, Yamada K. Dopamine D1 receptors regulate protein synthesis-dependent long-term recognition memory via extracellular signal-regulated kinase 1/2 in the prefrontal cortex. Learn Mem 2007, 14:117-125. 10.1101/lm.461407, 1838552, 17337702.
23. Glowinski J, Iversen LL. Regional studies of catecholamines in the rat brain. I. The disposition of [3H]norepinephrine, [3H]dopamine and [3H]dopa in various regions of the brain. J Neurochem 1966, 13:655-669. 10.1111/j.1471-4159.1966.tb09873.x, 5950056.
24. Chomczynski P, Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 1987, 162:156-159.
25. Kanbak G, Arslan OC, Dokumacioglu A, Kartkaya K, Inal ME. Effects of chronic ethanol consumption on brain synaptosomes and protective role of betaine. Neurochem Res 2008, 33:539-544. 10.1007/s11064-007-9472-0, 17763942.
26. Szczepanik AM, Ringheim GE. IL-10 and glucocorticoids inhibit Aβ(1-42)- and lipopolysaccharide-induced pro-inflammatory cytokine and chemokine induction in the central nervous system. J Alzheimers Dis 2003, 5:105-117.
27. Lehnardt S, Massillon L, Follett P, Jensen FE, Ratan R, Rosenberg PA, Volpe JJ, Vartanian T. Activation of innate immunity in the CNS triggers neurodegeneration through a Toll-like receptor 4-dependent pathway. Proc Natl Acad Sci USA 2003, 100:8514-8519. 10.1073/pnas.1432609100, 166260, 12824464.
28. Choi SH, Langenbach R, Bosetti F. Genetic deletion or pharmacological inhibition of cyclooxygenase-1 attenuate lipopolysaccharide-induced inflammatory response and brain injury. FASEB J 2008, 22:1491-1501. 2386977, 18162486.
29. Madsen KK, Clausen RP, Larsson OM, Krogsgaard-Larsen P, Schousboe A, White HS. Synaptic and extrasynaptic GABA transporters as targets for anti-epileptic drugs. J Neurochem 2009, 109(Suppl 1):139-144.
30. Borden LA. GABA transporter heterogeneity: pharmacology and cellular localization. Neurochem Int 1996, 29:335-356. 10.1016/0197-0186(95)00158-1, 8939442.
31. Bitoun M, Tappaz M. Gene expression of taurine transporter and taurine biosynthetic enzymes in brain of rats with acute or chronic hyperosmotic plasma. A comparative study with gene expression of myo-inositol transporter, betaine transporter and sorbitol biosynthetic enzyme. Brain Res Mol Brain Res 2000, 77:10-18.
32. Lien YH, Shapiro JI, Chan L. Effects of hypernatremia on organic brain osmoles. J Clin Invest 1990, 85:1427-1435. 10.1172/JCI114587, 296588, 2332498.
33. Bitoun M, Tappaz M. Gene expression of the transporters and biosynthetic enzymes of the osmolytes in astrocyte primary cultures exposed to hyperosmotic conditions. Glia 2000, 32:165-176. 10.1002/1098-1136(200011)32:2<165::AID-GLIA60>3.0.CO;2-2, 11008216.
34. Park MJ, Kim SR, Huh H, Jung JH, Kim YC. Betaine attenuates glutamate-induced neurotoxicity in primary cultured brain cells. Archives of Pharmacal Research 1994, 17:343-347.
35. Montoliu C, Humet M, Canales JJ, Burda J, Planells-Cases R, Sanchez-Baeza F, Carbonell T, Perez-Paya E, Messeguer A, Ferrer-Montiel A, Felipo V. Prevention of in vivo excitotoxicity by a family of trialkylglycines, a novel class of neuroprotectants. J Pharmacol Exp Ther 2002, 301:29-36. 10.1124/jpet.301.1.29, 11907154.